The estimated Net Worth of James P Moran is at least 133 千$ dollars as of 13 March 2024. James Moran owns over 220,834 units of IGC Pharma Inc stock worth over 132,636$ and over the last 3 years James sold IGC stock worth over 0$.
James has made over 2 trades of the IGC Pharma Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently James exercised 220,834 units of IGC stock worth 82,702$ on 13 March 2024.
The largest trade James's ever made was exercising 220,834 units of IGC Pharma Inc stock on 13 March 2024 worth over 82,702$. On average, James trades about 101,389 units every 116 days since 2022. As of 13 March 2024 James still owns at least 354,167 units of IGC Pharma Inc stock.
You can see the complete history of James Moran stock trades at the bottom of the page.
Over the last 17 years, insiders at IGC Pharma Inc have traded over 12,397,736$ worth of IGC Pharma Inc stock and bought 1,543,722 units worth 473,972$ . The most active insiders traders include Ram Mukunda、Steven Michael Oliveira、Zwirn & Co., L.P.Zwirn Dani.... On average, IGC Pharma Inc executives and independent directors trade stock every 143 days with the average trade being worth of 93,624$. The most recent stock trade was executed by Ram Mukunda on 13 March 2024, trading 1,184,585 units of IGC stock currently worth 443,627$.
igc is developing a product portfolio of phytocannabinoid-based therapies through leading edge research for the treatment of a wide range of therapeutic indications. these include neuropathic and cancer pain, epilepsy, end of life supportive care, adjunctive supportive therapies of chronic neurological and oncological diagnosis, which are life altering or life threatening our mission is to treat pain, ptsd, seizures, cachexia, chronic and terminal neurological and oncological diagnoses, and other life altering conditions with phytocannabinoid-based treatments
IGC Pharma Inc executives and other stock owners filed with the SEC include: